ASKA Pharma, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 12%
4886 ASKA Pharmaceutical Holdings Co.,Ltd. 【J-GAAP】
Earnings ReportASKA Pharmaceutical Holdings Co.,Ltd. <4886> [TSE Prime] announced its financial results after the market closed on November 4th (16:10). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) decreased 19.7% from the same period last year to 2.66 billion yen.
In addition, the full-year forecast for consolidated ordinary profit has decreased 11.8%, from the previous forecast of 6.80 billion yen to 6.00 billion yen (compared to 5.10 billion yen in the previous period), leading to a reduction in the profit growth rate from 33.2% to 17.5%.
Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to expand 86.1% from the same period last year, reaching 3.34 billion yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit dropped to 1.04 billion yen, a 30.6% decrease compared to the same period last year. The operating profit margin drastically worsened from 9.9% in the same period last year to 6.6%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
31,648M | 3,055M | 3,096M | 4,129M | 145.9 | 47.5 | Nov 6, 2023 | J-GAAP |
|
|
32,371M | 3,345M | 3,312M | 2,560M | 90.4 | 64.9 | Nov 5, 2024 | J-GAAP |
|
|
35,253M | 2,649M | 2,660M | 2,226M | 78.5 | 44.3 | Nov 4, 2025 | J-GAAP |
| YoY | +8.9% | -20.8% | -19.7% | -13.0% | -13.1% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | － | 27 | May 12, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 35,253M | 2,649M | 2,660M | 2,226M | 78.5 | 27 | Nov 4, 2025 | J-GAAP |
| Revision Rate | － | － | － | － | － |
Guidance Update
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2026 Prev | 75,000M | 6,800M | 6,800M | 5,200M | 183.1 | 55 | May 12, 2025 | J-GAAP |
| Mar, 2026 New | 71,000M | 6,000M | 6,000M | 5,000M | 176.1 | 55 | Nov 4, 2025 | J-GAAP |
| Revision Rate | -5.3% | -11.8% | -11.8% | -3.8% | -3.8% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
31,768M | 1,986M | 1,795M | 2,541M | 89.6 | 30 | May 12, 2025 | J-GAAP |
|
Guidance
Oct - Mar, 2025
|
35,747M | 3,351M | 3,340M | 2,774M | 97.7 | 28 | Nov 4, 2025 | J-GAAP |
| YoY | +12.5% | +68.7% | +86.1% | +9.2% | +9.0% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
62,843M | 6,500M | 6,522M | 7,545M | 266.5 | 40 | May 10, 2024 | J-GAAP |
|
|
64,139M | 5,331M | 5,107M | 5,101M | 180.0 | 55 | May 12, 2025 | J-GAAP |
|
Guidance
Mar, 2026
|
71,000M | 6,000M | 6,000M | 5,000M | 176.1 | 55 | Nov 4, 2025 | J-GAAP |
| YoY | +10.7% | +12.5% | +17.5% | -2.0% | -2.2% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
16,019M | 1,587M | 1,499M | 1,287M | 45.4 | 9.9 | Nov 5, 2024 | J-GAAP |
|
|
17,555M | 2,150M | 2,134M | 1,538M | 54.3 | 12.2 | Feb 3, 2025 | J-GAAP |
|
|
14,213M | -164M | -339M | 1,003M | 35.4 | -1.2 | May 12, 2025 | J-GAAP |
|
|
17,641M | 1,479M | 1,620M | 1,244M | 43.9 | 8.4 | Aug 4, 2025 | J-GAAP |
|
|
17,612M | 1,170M | 1,040M | 982M | 34.6 | 6.6 | Nov 4, 2025 | J-GAAP |
| YoY | +9.9% | -26.3% | -30.6% | -23.7% | -23.8% |
Related Articles
-
Mitsui O.S.K.Lines, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 11%, Dividend Revised Upward by 25 Yen
Tue Nov 4, 2025 12:00 pm JST Earnings -
Daikokuya Holdings, Net Income Forecast for the Fiscal Year Revised Downward to a Loss, 68% Deficit Against Net Assets
Fri Oct 31, 2025 6:00 pm JST Revision -
Nikkei 225 close on the 4th = falling for the first time in 4 days, 914 yen lower to 51,497 yen
Tue Nov 4, 2025 3:32 pm JST Market -
Insource, 13% Increase in Ordinary Profit, Update Record High for Sixth Consecutive Term, Increased Previous Year's Dividend by 1.5 Yen, This Fiscal Year to Increase Dividend by 4.5 Yen
Tue Nov 4, 2025 5:00 pm JST Earnings -
Hokuhoku Financial, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 20%, Highest in Nineteen Terms, Dividend Revised Upward by 20 Yen
Tue Nov 4, 2025 4:15 pm JST Revision -
MARUSAN-AI, 52% Decrease in Ordinary Profit for The Current Fiscal Year, Despite Last Fiscal Year's Dividend Increase, This Fiscal Year to Decrease Dividend
Tue Nov 4, 2025 4:00 pm JST Earnings -
HIROSE ELECTRIC, Net Income Forecast for the Fiscal Year Revised Upward by 7%
Tue Nov 4, 2025 4:00 pm JST Earnings -
Nakabohtec Corrosion Protecting, First Half Ordinary Profit Turns to Loss, Jul-Sep Ordinary Profit Decreases by 36%
Tue Nov 4, 2025 4:00 pm JST Earnings -
ASTMAX, First Half Ordinary Profit Turns to Loss, Jul-Sep Ordinary Profit Turns to Loss
Tue Nov 4, 2025 4:00 pm JST Earnings -
Cocolonet, First Half Ordinary Profit Increases by 38%, Jul-Sep Ordinary Profit Increases by 80%
Tue Nov 4, 2025 4:00 pm JST Earnings